S100A7/Psoriasin Polyclonal antibody

S100A7/Psoriasin Polyclonal Antibody for WB, IF, IHC, ELISA

Host / Isotype

Rabbit / IgG







Cat no : 13061-1-AP


Protein S100 A7, PSOR1, Psoriasin, S100A7, S100A7/Psoriasin, S100A7c

Tested Applications

Positive WB detected inMCF-7 cells
Positive IHC detected inhuman oesophagus cancer tissue, human breast cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF detected inMCF-7 cells

Recommended dilution

Western Blot (WB)WB : 1:200-1:1000
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)IF : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

13061-1-AP targets S100A7/Psoriasin in WB, IF, IHC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen S100A7/Psoriasin fusion protein Ag3738
Full Name S100 calcium binding protein A7
Calculated Molecular Weight 101 aa, 11 kDa
Observed Molecular Weight 11 kDa
GenBank Accession NumberBC034687
Gene Symbol S100A7
Gene ID (NCBI) 6278
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

S100A7 (psoriasin), a member of the S100 protein family, is a well-known antimicrobial peptide and a signaling molecule which regulates cellular function and is expressed in many squamous cell carcinomas (SCCs), such as SCC of the skin. It is an EF-hand type calcium binding protein localized in epithelial cells, regulates cell proliferation and differentiation. The protein is overexpressed in hyperproliferative skin diseases, exhibits antimicrobial activities against bacteria and induces immunomodulatory activities.


Product Specific Protocols
WB protocol for S100A7/Psoriasin antibody 13061-1-APDownload protocol
IHC protocol for S100A7/Psoriasin antibody 13061-1-APDownload protocol
IF protocol for S100A7/Psoriasin antibody 13061-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols



J Eur Acad Dermatol Venereol

TOPK promotes the development of psoriasis and worenine alleviates psoriasiform dermatitis by inhibiting TOPK activity

Authors - Hui Lu

J Eur Acad Dermatol Venereol

Differentially expressed proteins identified by TMT proteomics analysis in children with verrucous epidermal naevi.

Authors - T Yuan

BMC Cancer

A novel metabolic subtype with S100A7 high expression represents poor prognosis and immuno-suppressive tumor microenvironment in bladder cancer

Authors - Yun Cai

Cell Biol Int

S100A7 promotes the development of human endometriosis by activating NF-κB signaling pathway in endometrial stromal cells.

Authors - Qingqing Sun

Oncol Lett

PSMC2, ORC5 and KRTDAP are specific biomarkers for HPV-negative head and neck squamous cell carcinoma.

Authors - Yushen Su

Mol Med Rep

TET2 is involved in DNA hydroxymethylation, cell proliferation and inflammatory response in keratinocytes.

Authors - Xinxin Liu